<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(1)</volume><submitter>Tekoh TA</submitter><pubmed_abstract>Metabolic resistance to pyrethroids driven by cytochrome P450s is threatening malaria control interventions and may provide cross-resistance to insecticides with unrelated modes of action. Here, we show that cytochrome P450 genes CYP6P9a/b associated with pyrethroid resistance in Anopheles funestus also confer cross-resistance to a novel mitochondrial complex I inhibitor insecticide, code-named Sherlock. Using standard bioassays (CDC bottle bioassays, WHO cone bioassays, and WHO tunnel tests), the Sherlock and pyrethroid insecticides were tested against pyrethroid-resistant An. gambiae s.s. (Nkolondom, Cameroon) and An. funestus s.s. (Mibellon, Cameroon) and FUMOZ-R). Molecular assays (genotyping of P450 markers and qRT-PCR expression) were performed to investigate the underlying resistanc</pubmed_abstract><journal>BMC genomics</journal><pagination>837</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12465288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The duplicated cytochrome P450 CYP6P9a/b confers cross-resistance to a mitochondrial complex I inhibitor in the African malaria vector Anopheles funestus.</pubmed_title><pmcid>PMC12465288</pmcid><pubmed_authors>Tekoh TA</pubmed_authors><pubmed_authors>Tchouakui M</pubmed_authors><pubmed_authors>Small G</pubmed_authors><pubmed_authors>Menze B</pubmed_authors><pubmed_authors>Tchapga W</pubmed_authors><pubmed_authors>Wondji M</pubmed_authors><pubmed_authors>Mugenzi LMJ</pubmed_authors><pubmed_authors>Wondji CS</pubmed_authors></additional><is_claimable>false</is_claimable><name>The duplicated cytochrome P450 CYP6P9a/b confers cross-resistance to a mitochondrial complex I inhibitor in the African malaria vector Anopheles funestus.</name><description>Metabolic resistance to pyrethroids driven by cytochrome P450s is threatening malaria control interventions and may provide cross-resistance to insecticides with unrelated modes of action. Here, we show that cytochrome P450 genes CYP6P9a/b associated with pyrethroid resistance in Anopheles funestus also confer cross-resistance to a novel mitochondrial complex I inhibitor insecticide, code-named Sherlock. Using standard bioassays (CDC bottle bioassays, WHO cone bioassays, and WHO tunnel tests), the Sherlock and pyrethroid insecticides were tested against pyrethroid-resistant An. gambiae s.s. (Nkolondom, Cameroon) and An. funestus s.s. (Mibellon, Cameroon) and FUMOZ-R). Molecular assays (genotyping of P450 markers and qRT-PCR expression) were performed to investigate the underlying resistanc</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T21:45:37.455Z</modification><creation>2026-05-02T03:08:39.316Z</creation></dates><accession>S-EPMC12465288</accession><cross_references><pubmed>41013195</pubmed><doi>10.1186/s12864-025-11984-1</doi></cross_references></HashMap>